F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of scientists from the around the world has warned. According to the scientists ...

Auto-brewery syndrome (ABS) is a rare condition where bacteria and fungi in the gut turn carbs in food into alcohol. Read ...

Read this Kerassentials review to find out if this formula effectively supports nail health by addressing fungal infections.

Discover the truth with our KeraBiotics reviews, exploring how this advanced probiotic mix can effectively combat toenail ...

Just ask Pablito, the Staffordshire Bull Terrier, who gets royalty treatment from two of her favorite humans whenever her ...

UK-based biopharmaceutical company F2G announced a $100 million financing round to advance late-stage development and ...

Olorofim is licensed in Europe and Asia to Japanese pharma Shionogi, which paid $100 million upfront for rights to the drug ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a renowned group ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...